drugset / Trial / NCT04085757

Optimal Timing of Dinoprostone Administration Prior to Office Hysteroscopy

NCT04085757

Phase 3 Completed 180 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to determine whether dinoprostone administered 10 hours before office hysteroscopy can relieve pain more effectively compared with dinoprostone administered 3 hours before office hysteroscopy.

Timeline

Start
2019-09-15
Primary completion
2019-12-15
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Other

Indications

No indication recorded.